| Market Cap | ₹1,00,368Cr |
| ROE | 13.89% |
| P/E Ratio(TTM) | 52.47 |
| EPS(TTM) | 46.34 |
| P/B Ratio | 7.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 34.91 |
| Book Value | 347.23 |
| Debt to Equity | 0.59 |
| Face Value | 1 |
| Parent Organisation | Mankind Pharma |
| Managing Director | Mr. Rajeev Juneja |
| NSE Symbol | MANKIND |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 39.22 | ||
| Cipla | NA (0.00%) | 23.76 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 18.66 | ||
| Zydus Lifesciences | NA (0.00%) | 21.48 |